03 April, 2017
This recall is being conducted following two confirmed worldwide reports of the device failing to activate. The devices, manufactured by Meridian Medical Technologies, were made between December 2015 and July 2016. The recalled devices may contain a defective part that could cause the pens to fail to activate.
EpiPen (0.3 mg epinephrine) auto-injector lot 5GU763, expiry date May 2017.
"What they're asking consumers to do is to check to see if their EpiPens are in these lots, and if so, to send them back so they can send replacements", Childs said. (0.15 mg) are sold as 2 Pak Auto-Injectors.
The defect makes it hard for the EpiPen to work during an emergency and could have significant health consequences for someone who is experiencing an allergic reaction.
Derrick Rose needs surgery again
Knicks guard Derrick Rose will miss the last few games of the season after tearing the meniscus in his left knee. In his first season with the Knicks, Rose averaged 18 points per game and 4.4 assists per game.
Dak Prescott celebrates Mississippi State OT upset over UConn
Vivians had 19 points, William had 13, Richardson had 12 and McCowan finished with 10 for the Bulldogs (34-4). On Sunday, the Lady Bulldogs will attempt to add their name to history against SEC rival SC .
In Trump's White House drama, Priebus is favorite target
In that review, the GAO estimated that an official speech in IL , followed by a golf weekend in Florida, cost about $3.6 million. Trump's lawyer pledged at a January 11 news conference to donate Trump Hotel profits from foreign governments to the Treasury.
For more information about the recall, visit the Health Canada website. The St.Louis, Missouri-based company initially did not include the United States in the recall, but later added them to the list. No device failures have been reported in the United States.
The U.S. recall follows an global recall of roughly 81,000 EpiPens in Australia, New Zealand, Europe and Japan in March.
Mylan is already suffering from bad PR after the company introduced a 600 percent price hike for the life saving device a year ago, an increase the CEO argued was "fair".
"We are asking patients to keep their existing product until their replacement product can be secured", the company said.